Brief: Kuros Biosciences AG Says All Agenda Items Were Approved At Its Extraordinary General Meeting
Oct 5 (Reuters) - Kuros Biosciences AG KURN.S :
* ALL AGENDA ITEMS WERE APPROVED AT ITS EXTRAORDINARY
GENERAL
MEETING TODAY
* LAUNCHES A DISCOUNTED RIGHTS OFFERING EXPECTED TO RAISE UP
TO
CHF 15.2 MILLION OF GROSS PROCEEDS
* PROPOSED INCREASE IN ORDINARY SHARE CAPITAL OF UP TO CHF
9.0
MILLION
* PROPOSED ISSUANCE OF UP TO AN ADDITIONAL 9,000,000
REGISTERED
SHARES WITH A NOMINAL VALUE OF CHF 1.00 EACH
Source text for Eikon: ID:
Further company coverage: KURN.S
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Kuros Biosciences AG
See all newsSwitzerland's Kuros Biosciences swing to H1 profit as revenue jumps
Brief: Kuros Biosciences H1 Gross Profit USD 79.965 Million
Europe Research Roundup: Avanza Bank, Forvia, Novonesis
Switzerland's Kuros Biosciences 2025 total medical device revenue rises, helped by MagnetOs growth
Brief: Kuros Biosciences FY Net Income USD 2.462 Million